본문 바로가기
KERD
논문KCI 등재

갑상샘 종양에서 p53, cyclin D1 및 c-myc 발현의 의의

Significance of p53, cyclin D1 and c-myc Expressions in Thyroid Tumors

이미자|전호종|이주호
대한병리학회|2004.02|Journal of Pathology and Translational Medicine|제38권 제1호|pp. 29-34

3

조회

0

다운로드

3

인용

0

참고문헌

주제분류병리학

초록

Abstract

Background : Elafin is a potent anti-elastase in human saliva, and is supposed to play a role in preventing oral ulceration. The expression of elafin was observed in the oral lichen planus (OLP), one of the most common noninfectious oral mucosal diseases, which frequently manifests as extensive ulceration on the involved oral mucosa. Methods : 50 OLP, 10 oral leukoplakia, 3 inflammatory oral ulcers, and 3 normal oral mucosa cases were fixed with 10% buffered formalin, and immunohistochemically stained with monoclonal elafin antibody. Representative specimens were fixed with 4% paraformaldehyde, and RNA in situ hybridization, with an elafin RNA probe, was performed. Results : With both the immunohistochemistry and RNA in situ hybridization the expression of elafin was more decreased in the OLP compared to the normal mucosa, while in the hyperplastic epithelium of the leukoplakia and inflammatory ulcers the expressions of elafin was more intense. In the thin epithelia of the reticular and atrophic OLPs the expressions of elafin were reduced compared to the normal mucosa, and became almost negative in the epithelium of the erosive OLP. Conclusions : These data suggested that the extensive ulceration of the OLP was closely relevant to the reduced expression of elafin in the involved epithelium.

참고문헌 (30)

  1. "Lichen planus and lichenoid lesionsof the oral cavity.", 103, pp.495~497 (1994)
  2. "Oral lichen planus:the clinical, historical, and therapeutic features of 100 cases", 70, pp.165~171 (1990)
  3. , 1993, 265~270
  4. "Oral lichen planus: epidemiology, clini-cal characteristics, and associated diseases.", 16, pp.273~277 (1997)
  5. "Squamous cell carcinoma of thetongue arising in lichen planus a case report and review of the lit-erature", 62, pp.175~178 (1998)
  6. ,, , 1989, 107~111
  7. "Oral lichen planus", 13, pp.87~90 (1994)
  8. "Oral lichen planus: clinical presentation andmanagement", 68, pp.494~499 (2002)
  9. "Recent advances on the pathogenesis of oral lichen planus(OLP).The adhesion molecules", 48, pp.151~159 (1999)
  10. "An immunohistochemical study of oral lichenplanus", 63, pp.60~67 (1987)
  11. "Photochemother-apy of oral lichen planus,A controlled study", 79, pp.554~558 (1995)
  12. "Vascular adhesion molecules in oral lichen planus", 81, pp.682~690 (1996)
  13. "Immune mechanisms in oral lichen planus", 59, pp.174~177 (2001)
  14. "The role of dental restorative metals in thepathogenesis of oral lichen planus", 57, pp.383~387 (1984)
  15. "Oral lichen planus:hypersensitivity to dental restoration material", 10, pp.11~15 (1984)
  16. "Oral manifestations of gold allergy", 30, pp.205~209 (1994)
  17. "Oral lichenoid lesions caused by allergy tomercury in amalgam fillings", 33, pp.423~427 (1995)
  18. "Oral lichen planus pathogenesis:A role for the HCV-specific cellular immune response", 36, pp.1446~1452 (2002)
  19. "Primary structure of the humanelafin precursor preproelafin deduced from the nucleotide sequenceof its gene and the presence of unique repetitive sequences in theprosegment", 185, pp.240~245 (1992)
  20. "an elastase inhibitor from culturedhuman keratinocytes Purification, cDNA sequence, and evidencefor transglutaminase cross-linking.", 268, pp.12028~12032 (1993)
  21. "Characterization and gene sequence of theprecursor of elafin an elastase-specific inhibitor in bronchial secre-tions", 8, pp.439~445 (1993)
  22. "Increased elafinexpression in cystic,dysplastic and neoplastic oral tissues.", 25, pp.135~139 (1996)
  23. "Elafin expression in human fetal andadult submandibular glands", 117, pp.423~430 (2002)
  24. "Differential expression of SKALP", Elafin in humanepidermal tumors, 1993, pp.143, 1679~1687
  25. "Levels of skin-derived antileukoproteinase", elafinin serum correlate with disease activity during treatment of severepsoriasis with cyclosporin A, 1995, pp.104, 189~193
  26. "an elastase-specific inhibitor of human skin ^Purification^char-acterization^and complete amino acid sequence^J Biol Chem 1990;구강 편평태선에서 Elafin265", 265, pp.14791~14795 (1990)
  27. "Elafin is a potent inhibitor ofproteinase 3", 174, pp.6~10 (1991)
  28. "Immunoelectronmicroscopic study of distribution of T cell subsets in oral lichenplanus", 97, pp.361~367 (1989)
  29. "Repopulation response of mouse oralmucosa during unconventional radiotherapy protocols", 37, pp.230~236 (1995)
  30. "Kinetics of the inhibition of human leukocyteelastase by elafin a 6-kilodalton elastase-specific inhibitor from humanskin", 32, pp.1866~1874 (1993)

관련 논문AI추천

갑상선유두암에서 p53과 Cyclin D1의 발현이 가지는 예후인자로서의 의미류정원, 석재연, 이영돈, 정동해, 정유승대한내분비외과학회 · Journal of Endocrine Surgery2015 · 제15권 제2호양성 및 악성 갑상샘 병변에서의 galectin-3, skp2, p27, cyclin D1 발현의 연관성권귀영, 김미경, 홍민의, 홍순억대한병리학회 · Journal of Pathology and Translational Medicine2008 · 제42권 제3호증식성 갑상샘조직과 갑상샘암종에서 Id-1과 Id-2의 발현김영아, 김지은, 박도준, 박성회, 박영주대한병리학회 · Journal of Pathology and Translational Medicine2006 · 제40권 제1호갑상샘종양의 감별진단에서 Galectin-3, Cytokeratin 19, p53, Ki-67의 유용성강대영, 박문일대한병리학회 · Journal of Pathology and Translational Medicine2006 · 제40권 제2호갑상선 종양에서 Galectin-3 발현의 임상적 의의김진환, 노영수, 신형식, 안회영, 오소정, 조성진, 한동혁대한이비인후과학회 · 대한이비인후과학회지 두경부외과학2006 · 제49권 제8호유두암과 여포 암에서 p53, Cylcin D1, Galectin-3 발현의 상관 관계백운철대한임상검사과학회 · 대한임상검사과학회지2013 · 제45권 제1호

이 간행물의 다른 논문 (12건)

Ginsenoside Rb1이 C6 Glioma 세포주의 Nitric Oxide 생성과 세포자멸사에 미치는 효과박주현, 박지영, 김선주, 이수경, 이윤희, 곽은경, 손윤경, 강구성pp. 1-7대장 종양에서 CD43의 발현에 관한 연구배영미, 장명철, 안혜경, 채기봉, 정경천, 김혜은, 최원진, 김우진, 노혜린, 박원서pp. 8-14구강 편평태선에서 Elafin의 발현이상신, 이석근pp. 15-22식도암으로 인한 식도절제술 후 둘레절제가장자리 병발의 유의성노미숙, 이재익, 최필조pp. 23-28위샘암종에서 FHIT와 p21의 발현강석진, 강창석, 최현주, 유진영, 김병기pp. 35-41
원문 보기